Cargando…

Painful ejaculation induced by venlafaxine: a case report

INTRODUCTION: Sexual dysfunction is a quite common side effect of antidepressant treatment. Sexual side effects may affect the person’s adherence to treatment, quality of life, and relations. Premature ejaculation is rarely seen as an adverse effect of antidepressant drugs. OBJECTIVES: We aimed to p...

Descripción completa

Detalles Bibliográficos
Autor principal: Kulacaoglu, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567160/
http://dx.doi.org/10.1192/j.eurpsy.2022.2071
_version_ 1784809332183924736
author Kulacaoglu, F.
author_facet Kulacaoglu, F.
author_sort Kulacaoglu, F.
collection PubMed
description INTRODUCTION: Sexual dysfunction is a quite common side effect of antidepressant treatment. Sexual side effects may affect the person’s adherence to treatment, quality of life, and relations. Premature ejaculation is rarely seen as an adverse effect of antidepressant drugs. OBJECTIVES: We aimed to present a clinical case of a 53-year-old man who developed painful ejaculation with the use of venlafaxine. METHODS: We made a narrative literature search in Pubmed and Google scholar with the terms of painful ejaculation induced by venlafaxine and antidepressant treatment. RESULTS: A 53-year-old man was admitted to the psychiatric outpatient unit with symptoms of anhedonia, decreased sleep, decreased self-esteem for the last month. The patient was diagnosed with depression and he started to take 37,5 mg venlafaxine per day. After one month, when venlafaxine dose was increased to 75mg and the patient started to complain of painful ejaculation. The pain continued from the beginning to the end of the ejaculation. The pain increased more when the venlafaxine dose increased to 150mg per day. The patient was consulted at the urology clinic. The urological examination, laboratory tests (direct microscopic examination of the urethral discharge and urethral culture), and serum prostate-specific antigen levels were normal. No pathology was found in uroflowmetry and ultrasonography of the urinary system. The dose of venlafaxine decreased and the patient started to take 20 mg of fluoxetine per day. His symptoms disappeared after venlafaxine was discontinued. CONCLUSIONS: To literature, this is the second presentation of painful ejaculation observed during the use of venlafaxine. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9567160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95671602022-10-17 Painful ejaculation induced by venlafaxine: a case report Kulacaoglu, F. Eur Psychiatry Abstract INTRODUCTION: Sexual dysfunction is a quite common side effect of antidepressant treatment. Sexual side effects may affect the person’s adherence to treatment, quality of life, and relations. Premature ejaculation is rarely seen as an adverse effect of antidepressant drugs. OBJECTIVES: We aimed to present a clinical case of a 53-year-old man who developed painful ejaculation with the use of venlafaxine. METHODS: We made a narrative literature search in Pubmed and Google scholar with the terms of painful ejaculation induced by venlafaxine and antidepressant treatment. RESULTS: A 53-year-old man was admitted to the psychiatric outpatient unit with symptoms of anhedonia, decreased sleep, decreased self-esteem for the last month. The patient was diagnosed with depression and he started to take 37,5 mg venlafaxine per day. After one month, when venlafaxine dose was increased to 75mg and the patient started to complain of painful ejaculation. The pain continued from the beginning to the end of the ejaculation. The pain increased more when the venlafaxine dose increased to 150mg per day. The patient was consulted at the urology clinic. The urological examination, laboratory tests (direct microscopic examination of the urethral discharge and urethral culture), and serum prostate-specific antigen levels were normal. No pathology was found in uroflowmetry and ultrasonography of the urinary system. The dose of venlafaxine decreased and the patient started to take 20 mg of fluoxetine per day. His symptoms disappeared after venlafaxine was discontinued. CONCLUSIONS: To literature, this is the second presentation of painful ejaculation observed during the use of venlafaxine. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567160/ http://dx.doi.org/10.1192/j.eurpsy.2022.2071 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Kulacaoglu, F.
Painful ejaculation induced by venlafaxine: a case report
title Painful ejaculation induced by venlafaxine: a case report
title_full Painful ejaculation induced by venlafaxine: a case report
title_fullStr Painful ejaculation induced by venlafaxine: a case report
title_full_unstemmed Painful ejaculation induced by venlafaxine: a case report
title_short Painful ejaculation induced by venlafaxine: a case report
title_sort painful ejaculation induced by venlafaxine: a case report
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567160/
http://dx.doi.org/10.1192/j.eurpsy.2022.2071
work_keys_str_mv AT kulacaogluf painfulejaculationinducedbyvenlafaxineacasereport